Shares of Hiscox Ltd (LON:HSX - Get Free Report) hit a new 52-week high on Wednesday . The stock traded as high as GBX 1,622 and last traded at GBX 1,586, with a volume of 156491 shares traded. The stock had previously closed at GBX 1,584.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on HSX shares. The Goldman Sachs Group upped their price objective on Hiscox from GBX 1,560 to GBX 1,713 and gave the stock a "buy" rating in a research report on Wednesday, January 21st. Jefferies Financial Group upped their price objective on Hiscox from GBX 1,068 to GBX 1,148 and gave the stock an "underperform" rating in a research report on Thursday, March 5th. Four investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of GBX 1,466.83.
Check Out Our Latest Report on Hiscox
Hiscox Stock Performance
The business has a fifty day simple moving average of GBX 1,508.50 and a 200-day simple moving average of GBX 1,432.28. The firm has a market cap of £5.12 billion, a price-to-earnings ratio of 9.06, a PEG ratio of -2.30 and a beta of 0.36.
Hiscox Company Profile
(
Get Free Report)
Hiscox is a global, specialty insurer, listed on the London Stock Exchange and headquartered in Bermuda. We have grown from
our roots as a niche Lloyd's of London underwriter into a diversified international insurance group operating across direct‑to‑consumer, broker and partner‑distributed retail insurance; large and complex commercial insurance; reinsurance and insurance‑linked strategies.
We currently employ over 3,000 people worldwide across 13 countries and 31 offices. We have a distinctive brand, energised and ambitious teams, a strong balance sheet, and plenty of room to grow in each of our chosen markets and lines of business.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hiscox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hiscox wasn't on the list.
While Hiscox currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.